logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
J

Jordi Esteve

Hospital Clínic

68H指数
619论文数
2.0W被引数
收录论文 132
发表时间
logo
Correction: Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation更正：费城染色体阳性急性淋巴细胞白血病合并附加细胞遗传学异常的移植结局：欧洲血液与骨髓移植学会急性白血病工作组的研究
errBone Marrow Transplantation
IF5.2
err2026-08-31
err0
errOAAI
errArnon Nagler; Jordi Esteve; Jacques-Emmanuel Galimard; Depei Wu; Erlie Jiang; Nathalie Dhedin; Anne Sirvent; Jan Vydra; Jakob Passweg; Bruno Lioure; Jaime Sanz; Jurjen Versluis; Yajing Xu; Cristina Castilla-Llorente; Rodrigo Martino Bufarull; Victoria Potter; Nour Ben Abdeljelil; Eolia Brissot; Ali Bazarbachi; Bipin Savani; Sebastian Giebel; Mohamad Mohty; Fabio Ciceri
err分享
err收藏
Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities携带附加细胞遗传学异常的费城染色体阳性急性淋巴细胞白血病的移植结果
errBone Marrow Transplantation
IF5.2
err2026-07-13
err0
errOAAI
errArnon Nagler; Jordi Esteve; Jacques-Emmanuel Galimard; Depei Wu; Erlie Jiang; Nathalie Dhedin; Anne Sirvent; Jan Vydra; Jakob Passweg; Bruno Lioure; Jaime Sanz; Jurjen Versluis; Yajing Xu; Cristina Castilla-Llorente; Rodrigo Martino Bufarull; Victoria Potter; Nour Ben Abdeljelil; Eolia Brissot; Ali Bazarbachi; Bipin Savani; Sebastian Giebel; Mohamad Mohty; Fabio Ciceri
err分享
err收藏
Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP)544例t(6;9)/DEK::NUP214急性髓系白血病患者行异基因干细胞移植的结局：欧洲血液和骨髓移植组急性白血病工作组(ALWP)和儿科疾病工作组(PDWP)的代表性研究
errBone Marrow Transplantation
IF5.2
err2026-04-22
err0
PREAI
errFabio Andreozzi; Jacques-Emmanuel Galimard; Johan Maertens; Mahmoud Aljurf; Katherine Clesham; Jaime Sanz; Sebastien Maury; Sandrine Loron; Jakob Passweg; Thomas Schroeder; Urpu Salmenniemi; Gwendolyn van Gorkom; Regis Peffault de Latour; Peter A. von dem Borne; Franco Locatelli; Robert F. Wynn; Jean-Hugues Dalle; Jordi Esteve; Arnon Nagler; Katharina Kleinschmidt; Mohamad Mohty; Krzysztof Kalwak; Fabio Ciceri
err分享
err收藏
The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutationsDNMT3A基因突变对接受首次缓解期异基因移植的AML患者生存的影响，取决于核型及共现突变。
errBone Marrow Transplantation
IF5.2
err2025-12-23
err0
PREAI
errIman Abou Dalle; Jacques-Emmanuel Galimard; Xavier Poire; Jaime Sanz; Anne Huynh; Nicolaus Kröger; Eva Maria Wagner-Drouet; David Burns; Matthias Eder; Bruno Lioure; Depei Wu; Jiri Mayer; Kristina Carlson; Matthias Stelljes; Matthew Collin; Mahmoud Aljurf; Arnon Nagler; Jordi Esteve; Fabio Ciceri; Ali Bazarbachi; Mohamad Mohty
err分享
err收藏
Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working Party供者选择对不良风险AML接受造血细胞移植的影响：EBMT急性白血病工作组的研究
errBone Marrow Transplantation
IF5.2
err2025-11-29
err0
PREAI
errMarta Villalba; Allain-Thibeault Ferhat; Tobias Gedde-Dahl; Gerard Socie; Anne Huynh; Igor Wolfgang Blau; Ibrahim Yakoub-Agha; Didier Blaise; Matthias Eder; Edouard Forcade; Renato Fanin; Jakob Passweg; Charles Crawley; Matthias Stelljes; Friedrich Stölzel; Nicolaus Kroeger; Henrik Sengeloev; Patrice Ceballos; Helene Labussiere-Wallet; Xavier Poiré; Jordi Esteve; Bipin Savani; Arnon Nagler; Simona Piemontese; Jaime Sanz; Mohamad Mohty; Fabio Ciceri
err分享
err收藏
Impact of Wilms’ tumor 1 gene (WT1) mutation on outcome of allogeneic hematopoietic-cell transplantation for acute myeloid leukemia: a retrospective multicenter cohort study from the ALWP/EBMT registryWT1基因突变对急性髓系白血病异基因造血细胞移植结局的影响：一项来自ALWP/EBMT注册中心的回顾性多中心队列研究
errBone Marrow Transplantation
IF5.2
err2025-10-16
err0
errOAAI
errArnon Nagler; Jordi Esteve; Jacques-Emmanuel Galimard; Jaime Sanz; Xavier Poire; Matthew Collin; Johan Maertens; He Huang; Maija Itäla-Remes; Khalid Halahleh; Maria Jesús Pascual Cascon; Patrizia Chiusolo; Laimonas Griskevicius; Ain Kaare; Ann De Becker; Pavel Jindra; Jose Antonio Pérez-Simón; Ali Bazarbachi; Eolia Brissot; Fabio Ciceri; Mohamad Mohty
err分享
err收藏
A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias一种靶向CD84的新型嵌合抗原受体T细胞疗法，用于治疗急性髓系和T细胞淋巴母细胞白血病
errLeukemia
IF13.4
err2025-08-06
err0
errOAAI
errLorena Pérez-Amill; Mercedes Armand-Ugón; Maria Val-Casals; Beatriz Martín-Herreros; José R. Álamo; Sergio Peña; Gerard Frigola; Ane Altuna; Claudio Santos; Francesca Guijarro; Alfredo Minguela; Àlex Bataller; Berta Casanovas-Albertí; Mireia Uribe-Herranz; Irene Navarro; Manuel Guerreiro; Diego Sánchez-Martínez; Néstor Tirado; Talía Velasco-Hernandez; Pablo Menéndez; Antonio Martínez; Montse Rovira; Dolors Colomer; E. Azucena González-Navarro; Jordi Esteve; Álvaro Urbano-Ispizua; Pau Montesinos; Julio Delgado; Manel Juan; Nela Klein-González
err分享
err收藏
Enasidenib as treatment for AML with IDH2 mutation: multicenter real-life study of the early-access program in Spainenasidenib作为IDH2突变型急性髓系白血病的治疗：西班牙早期准入计划的多中心真实世界研究
errAnnals of Hematology
IF2.4
err2025-07-12
err0
errOAAI
errCarlos Jiménez-Vicente; Paola Beneit; Isabel Cano-Ferri; Brayan Merchán; Montserrat Arnan; Antoni García Guiñón; Cristina Martínez-Bilbao; Ana Alfonso; Pilar Martínez-Sánchez; Juan Manuel Alonso-Domínguez; Oriana López-Godino; Sandra Castaño-Díez; Inés Zugasti; Jordi Esteve; Marina Díaz-Beyá; Adolfo de la Fuente
err分享
err收藏
CAR-T cell therapy for cancer: current challenges and future directionsCar-t细胞治疗癌症: 当前挑战和未来方向
errSignal Transduction and Targeted Therapy
IF52.7
err2025-07-04
err0
errOAAI
errInés Zugasti; Lady Espinosa-Aroca; Klaudyna Fidyt; Vladimir Mulens-Arias; Marina Diaz-Beya; Manel Juan; Álvaro Urbano-Ispizua; Jordi Esteve; Talia Velasco-Hernandez; Pablo Menéndez
err分享
err收藏
A phase 1, first-in-human, dose-escalation study of JNJ-74856665 (dihydroorotate dehydrogenase inhibitor) alone or in combination in patients with AML or MDS一项关于JNJ-74856665（二氢乳清酸脱氢酶抑制剂）单药或联合用药治疗AML或MDS患者的1期、首次人体试验、剂量递增研究
errBritish Journal of Haematology
IF3.8
err2025-07-01
err0
errOAAI
errEmma Searle; Thomas Cluzeau; Jenny O'Nions; Christian Recher; Emmanuel Gyan; Daniel Morillo; Jordi Esteve; Austin Kulasekararaj; Emmanuel Raffoux
err分享
err收藏
Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations可测量残留病灶（MRD）对维奈克拉与表观遗传学药物联合治疗急性髓系白血病患者的预后价值：ELN-2021 MRD建议的验证
errBLOOD CANCER JOURNAL
IF11.6
err2025-05-14
err0
errOAAI
errJimenez-Vicente, Carlos; Cardus, Aina; Castano-Diez, Sandra; Ramil, Guillermo; Garcia-Avila, Sara; Gomez-Perez, Lucia; Esteban, Daniel; Arribas, Iago; Sturla, Antonella Lucia; Lopez-Guerra, Monica; Martinez-Roca, Alexandra; Cortes-Bullich, Albert; Perez-Valencia, Amanda Isabel; Zugasti, Ines; Monge, Ines; Carcelero, Esther; Vall-Llovera, Ferran; Vives, Susana; Sierra, Jorge; Nomdedeu, Josep; Onate, Guadalupe; Garrido, Ana; Pratcorona, Marta; Pomares, Helena; Arnan, Montserrat; Guijarro, Francesca; Diaz-Beya, Marina; Esteve, Jordi
err分享
err收藏
Frailty assessment and outpatient pre-habilitation for adults undergoing allogeneic hematopoietic cell transplantation老年评估和门诊预康复训练用于接受异基因造血细胞移植的成人
errBONE MARROW TRANSPLANTATION
IF5.2
err2025-04-08
err0
PREAI
errSalas, Maria Queralt; Salinas-Gonzalez, Raquel; Guardia, Laia; Solano, Maria Teresa; Padilla, Cristina; Moreno, Cristina; Charr, Paola; de Llobet, Noemi; Mestre, Carla; Cascos, Enric; Cid, Joan; Lozano, Miquel; Gallego, Cristina; Carreras, Bernat; Vilas, Vanessa; Duch, Montserrat; Martinez-Sanchez, Julia; Diaz-Ricart, Maribel; Esteve, Jordi; Carreras, Enric; Suarez-Lledo, Maria; Rosinol, Laura; Laxe, Sara; Closa, Concepcion; Martinez, Carmen; Fernandez-Aviles, Francesc; Rovira, Montserrat
err分享
err收藏
Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC)异基因造血细胞移植（Allo-HCT）精炼的ELN 2022风险分类：西班牙造血细胞移植组（GETH-TC）中AML患者接受异基因造血细胞移植时不良风险组（Adverse-Plus）的验证
errBLOOD CANCER JOURNAL
IF11.6
err2025-03-21
err0
errOAAI
errJimenez-Vicente, Carlos; Esteve, Jordi; Baile-Gonzalez, Monica; Perez-Lopez, Estefania; Martin Calvo, Carmen; Aparicio, Clara; Oiartzabal Ormategi, Itziar; Esquirol, Albert; Pena-Munoz, Felipe; Fernandez-Luis, Sara; Heras Fernando, Inmaculada; Gonzalez-Rodriguez, Ana Pilar; Lopez-Garcia, Alberto; Lopez-Lorenzo, Jose Luis; Torrado, Tamara; Marin, Adolfo Jesus Saez; Acosta Fleytas, Cynthia; Garcia, Lucia; Villar, Sara; Filaferro, Silvia; Balsalobre, Pascual; Pascual Cascon, Maria Jesus; Salas, Maria Queralt
err分享
err收藏
Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Genetic Features: Relevance of the Genetic Underlying Category. A Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMT异基因造血细胞移植在具有骨髓增生异常相关遗传特征的急性髓系白血病患者中的应用：遗传基础分型的相关性。代表EBMT急性白血病工作组的回顾性分析
errAMERICAN JOURNAL OF HEMATOLOGY
IF0
err2025-03-10
err1
PREAI
errEsteve, J; Nagler, A; Labopin, M; Versluis, J; Sanz, J; Gedde-Dahl, T; Burns, D; Roeven, M; Labussière-Wallet, H; Borne, PV; Van Gorkom, G; Contentin, N; Neubauer, A; Wagner-Drouet, EM; Kröger, N; Mohty, M; Ciceri, F
err分享
err收藏
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Single-Center Experience. Clinical Characterization, Mutational Landscape, and Clinical Outcome of Patients Undergoing Hematopoietic Stem Cell Transplantation Intensive Therapy
errACTAS DERMO-SIFILIOGRAFICAS
IF2.8
err2025-02-01
err0
errOAAI
errGil-Lianes, J.; Mozas, P.; Baumann, T.; Combalia, A.; Baliu-Pique, C.; Garcia, A.; Rovira, M.; Lopez-Guerra, M.; Villamor, N.; Colomer, D.; Rozman, M.; Esteve, J.; Estrach, T.
err分享
err收藏
Development and Validation of a Machine Learning Model for the Prediction of Bloodstream Infections in Patients with Hematological Malignancies and Febrile Neutropenia恶性血液病伴发热性中性粒细胞减少症患者血流感染预测的机器学习模型的建立与验证
errANTIBIOTICS-BASEL
IF4.6
err2024-12-28
err0
errOAAI
errGallardo-Pizarro, Antonio; Teijon-Lumbreras, Christian; Monzo-Gallo, Patricia; Aiello, Tommaso Francesco; Chumbita, Mariana; Peyrony, Olivier; Gras, Emmanuelle; Pitart, Cristina; Mensa, Josep; Esteve, Jordi; Soriano, Alex; Garcia-Vidal, Carolina
err分享
err收藏
Bleximenib Dose Optimization and Determination of RP2D from a Phase 1 Study in Relapsed/Refractory Acute Leukemia Patients with KMT2A and NPM1 AlterationsBleximenib剂量优化及携带KMT2A和NPM1基因变异的复发/难治性急性白血病患者1期研究的RP2D确定
errBLOOD
IF23.1
err2024-11-05
err5
PREAI
errSearle, Emma; Recher, Christian; Abdul-Hay, Maher; Abedin, Sameem; Aldoss, Ibrahim; Pierola, Ana Alfonso; Alonso-Dominguez, Juan M.; Chevallier, Patrice; Cost, Carrye; Daskalakis, Nikki; Dillon, Richard; Dunavin, Neil; Esteve, Jordi; Fathi, Amir T.; Fedele, Pasquale L.; Ferrante, Lucille; Gaj, Stan; Guttke, Christina; Gyan, Emmanuel; Hiebert, Brett; Jabbour, Elias; Kantarjian, Hagop M.; Kwon, Min Chul; Kumar, Anita J.; Ng, Teng Fong; Packman, Kathryn; Philippar, Ulrike; Pigneux, Arnaud; Salamero, Olga; Sanga, Madhu; Shastri, Prathap Nagaraja; Stone, Richard M.; Tan, Peter; Tucker, Trevor; Vyas, Paresh; Garciaz, Sylvain
err分享
err收藏
Prognostic Value of the Measurable Residual Disease (MRD) in AML Treatment with Venetoclax in Combination with Hypomethylating Agents: Validation of the ELN 2021 MRD Recommendations可测量残留病灶（MRD）在联合维奈克拉和表观遗传学抑制剂治疗的AML治疗中的预后价值：ELN 2021年MRD建议的验证
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errJimenez-Vicente, Carlos; Cardus, Aina; Lopez, Guillermo Ramil; Onate, Guadalupe; Arribas, Iago; Garcia-Avila, Sara; Gomez-Perez, Lucia; Esteban, Daniel; Sturla, Antonella; Guijarro, Francesca; Lopez-Guerra, Monica; Castano-Diez, Sandra; Martinez-Roca, Alexandra; Cortes-Bullich, Albert; Perez, Amanda Isabel; Zugasti, Ines; Monge-Escartin, Ines; Sierra, Jorge; Vives, Susana; Pomares, Helena; Arnan, Montserrat; Nomdedeu, Josep; Garrido, Ana; Pratcorona, Marta; Diaz-Beya, Marina; Esteve, Jordi
err分享
err收藏
Challenging the Adverse Label: Diverse Outcomes of ELN 2022 Adverse Cytogenetic Subgroups in Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation in First Remission: On Behalf of the EBMT Acute Leukemia Working Party挑战不良标签：急性髓系白血病患者在首次缓解期接受 allo-HCT 时，ELN 2022 不良细胞遗传学亚组的不同结局：代表 EBMT 急性白血病工作组。
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errBazarbachi, Ali; Galimard, Jacques-Emmanuel; Dalle, Iman Abou; De Fontbrune, Flore Sicre; Versluis, Jurjen; Wu, Depei; Eder, Matthias; Labussiere-Wallet, Helene; Yakoub-Agha, Ibrahim; Maertens, Johan; Forcade, Edouard; Gedde-Dahl, Tobias; Choi, Goda; Castilla-Llorente, Cristina; Baron, Frederic; Brissot, Eolia; Esteve, Jordi; Nagler, Arnon; Mohty, Mohamad; Ciceri, Fabio
err分享
err收藏
Clinical management of patients diagnosed with acute myeloid leukemia treated with venetoclax in combination with hypomethylating agents after achieving a response: a real-life studyvenetoclax联合低甲基化剂治疗的急性髓性白血病患者的临床管理: 一项现实生活研究
errANNALS OF HEMATOLOGY
IF2.4
err2024-08-29
err1
errOAAI
errJimenez-Vicente, Carlos; Guardia-Torrelles, Ares; Perez-Valencia, Amanda Isabel; Martinez-Roca, Alexandra; Castano-Diez, Sandra; Guijarro, Francesca; Cortes-Bullich, Albert; Merchan, Beatriz; Triguero, Ana; Hernandez, Isabel; Brillembourg, Helena; Munarriz, Daniel; Zugasti, Ines; Fernandez-Aviles, Francesc; Diaz-Beya, Marina; Esteve, Jordi
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
H
Hagop M. Kantarjian
H 指数: 230 · 论文数: 5.5K
E
Elı́as Campo
H 指数: 173 · 论文数: 1.6K
H
Hartmut Döhner
H 指数: 146 · 论文数: 1.4K
P
Peter Valent
H 指数: 131 · 论文数: 1.5K
M
Marina Konopleva
H 指数: 130 · 论文数: 2.1K
查看更多